Google Reader is back.
And it has a brain.
Kelp reads your industry's top sources and delivers a weekly briefing with the insights that matter.
Example Briefing
25 articles analyzed
Executive Summary
FDA shifted focus from telehealth enforcement to drug importation and faster rare disease approvals [1][14][19]. Medicare Advantage insurers face scrutiny after a lobbying group submitted 16,400 identical comments to raise payment rates [6][15][16]. Epic Systems confronts legal action claiming separate patient portals block disability benefit access, escalating last week's data interoperability concerns [7][13][2].
Key Takeaways
- Medicare Advantage payment rates face political pressure: A secretive group funded $3.1 million in ads to generate identical public comments.
- EHR vendors risk liability for data access: AADJ sues Epic because separate MyChart portals prevent patients from aggregating records for SSDI claims.
- Medicaid drug budgets swell: Net spending rose 46% from FY2019 to FY2024 driven by specialty drugs.
- FDA accelerates rare disease reviews: The National Priority Voucher program approved a myeloma treatment in 55 days.
Key Themes
FDA Regulatory Changes
Agency upgrades data tools and accelerates rare disease approvals.
Medicare Advantage Payment Pressure
Insurers lobby for higher rates while plan terminations disrupt beneficiaries.
Health Data Interoperability Litigation
Lawsuits target EHR vendors over patient access barriers.
Regulatory & Policy Updates
FDA launches real-time adverse event tracking.
Replaces 7 older databases with single platform for public data access.
CMS/MEDICARECMS faces lobbying pressure on 2027 rates.
Industry group opposes flat reimbursement proposals.
FDAFDA vaccine chief resigns amid policy conflicts.
Trust in career scientists exceeds political leaders.
What to Watch
RFK Jr. Vaccine Policy
Q2 202686% of voters support vaccines despite HHS agenda.
Statin Guidelines
ImmediateAge threshold drops to 30 for high LDL patients.
Epic Antitrust Case
2026Texas court rules on 'covered entity' status.
Explore Topics
Discover briefings in related industries